Rhythm Pharmaceuticals Correlations
| RYTM Stock | USD 53.32 2.29 4.49% |
The current 90-days correlation between Rhythm Pharmaceuticals and Beam Therapeutics is 0.28 (i.e., Modest diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Rhythm Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Rhythm Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
Rhythm Pharmaceuticals Correlation With Market
Significant diversification
The correlation between Rhythm Pharmaceuticals and DJI is 0.05 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Rhythm Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.
Rhythm |
Moving against Rhythm Stock
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Rhythm Stock performing well and Rhythm Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Rhythm Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| BEAM | 3.40 | 0.24 | 0.06 | 0.24 | 3.78 | 8.04 | 21.42 | |||
| EDIT | 6.37 | 0.24 | 0.03 | 0.11 | 8.46 | 12.04 | 119.53 | |||
| CRBU | 3.00 | (0.63) | 0.00 | (1.55) | 0.00 | 8.22 | 17.35 | |||
| VERV | 5.44 | 0.78 | 0.15 | 0.28 | 4.82 | 11.24 | 36.90 | |||
| NTLA | 3.59 | (0.32) | 0.00 | 0.54 | 0.00 | 7.84 | 22.98 | |||
| FATE | 5.42 | (0.71) | 0.00 | (0.31) | 0.00 | 11.34 | 34.46 | |||
| REGN | 1.41 | (0.07) | 0.00 | 0.13 | 0.00 | 2.15 | 8.14 | |||
| NVO | 2.05 | (0.16) | 0.00 | 0.73 | 0.00 | 4.36 | 20.40 | |||
| SRPT | 1.74 | 0.06 | 0.03 | (0.23) | 2.19 | 3.98 | 19.63 | |||
| HEPA | 7.67 | (1.29) | 0.00 | (1.46) | 0.00 | 17.65 | 86.86 |
Rhythm Pharmaceuticals Corporate Management
| Jennifer Lee | Executive America | Profile | |
| Yann Mazabraud | Executive International | Profile | |
| Christopher German | Principal Controller | Profile | |
| Sarah Ryan | Vice Marketing | Profile | |
| Jim Flaherty | Senior Counsel | Profile | |
| David Connolly | Head Communications | Profile | |
| Joseph Shulman | Chief Officer | Profile |